Litigation in Generic Markets: How Patent Disputes Delay Affordable Medicines
Patent disputes in the generic drug market are delaying affordable medications for millions. Learn how the Hatch-Waxman Act, Orange Book listings, and serial litigation are driving up drug costs-and what’s being done to fix it.
Continue reading...